Oregon Center for Complementary & Alternative Medicine in Neurological

Status Completed

Clinical Trial Summary

The mission of the Oregon Center for Complementary and Alternative Medicine in Neurological Disorders (ORCCAMIND) is to facilitate research and education on the effectiveness and mechanisms of action of complementary and alternative medicine (CAM) therapies in the treatment of neurological disorders. The integration of conventional medicine and CAM communities is critical for the success of ORCCAMIND. Thus, ORCCAMIND is composed of six institutions: Oregon Health Sciences University; National College of Naturopathic Medicine; Western States Chiropractic College; Oregon College of Oriental Medicine; the Linus Pauling Institute at Oregon State University; and the Portland Veterans Affairs Medical Center.

ORCCAMIND will initially focus on the use of CAM antioxidants and stress reduction as treatments for neurodegenerative and demyelinating diseases because many of these diseases have oxidative injury as a causative or contributory factor and several CAM approaches have direct or indirect anti-oxidant effects. Through the Career Development Program the Developmental Research Program and the activities of the Education and Information Core, we will also foster and promote research into other CAM approaches for neurologic diseases that extend beyond anti-oxidant therapies. ORCCAMIND will achieve its goals by carrying out 4 Research Projects and maintaining 4 Core facilities that integrate the research strengths of conventional medicine and CAM practitioners and researchers. ORCCAMIND draws its strength from the multi-institutional support and the quality of all its investigators. The investigators join ORCCCAMIND with extensive experience with clinical trials, patient care, externally funded basic and clinical neuroscience research, and training programs, including federally-funded training grants. ORCCAMIND is a bold initiative that integrates basic and clinical research scientists, conventional neurologists and CAM practitioners. It will promote the exploration of new areas of CAM research and lead research on CAM therapies for neurological disorders.

Clinical Trial Description

See brief summary ;

Study Design

Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00010881
Study type	Interventional
Source	National Center for Complementary and Integrative Health (NCCIH)
Contact
Status	Completed
Phase	N/A
Start date	September 1999
Completion date	December 2004

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01589289` - Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC	Phase 3
Recruiting	`NCT04461821` - Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry in Children and Adolescents
Completed	`NCT04094571` - Muscle Delay Characterization	N/A
Completed	`NCT04072536` - Evaluation on Standardized Circuits of the Interest of a Robotic Module of Assistance to the Driving	N/A
Recruiting	`NCT02795052` - Neurologic Stem Cell Treatment Study	N/A
Completed	`NCT02219269` - A Complex Contraception Registry	N/A
Completed	`NCT00122174` - Stress-Busting Program for Caregivers of Patients With Neruological Diseases	N/A
Recruiting	`NCT01524276` - Product Surveillance Registry
Completed	`NCT00532571` - Effects of Coenzyme Q10 in PSP and CBD	Phase 2/Phase 3
Completed	`NCT05830981` - Valproic Acid Use in Patients With Neurological Disorders
Completed	`NCT01754168` - Amyloid Beta and Cognition in Parkinson Disease	N/A
Completed	`NCT02780531` - Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases
Completed	`NCT01858350` - Comparison of the Effectiveness of CAM Therapies in Pediatric Patients Undergoing Sedation	N/A
Suspended	`NCT05212727` - Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders
Recruiting	`NCT01266382` - The Effect of AposTherapy on the Level of Pain, Function and Quality of Life in Patients With Neuro-muscular and Neurological Disorders	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.